Increased Serum Soluble Urokinase Plasminogen Activator Receptor Predicts Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure

AIMS: Soluble urokinase plasminogen activator receptor (suPAR) reflects the immune activation in circumstances of inflammation and infection. It has been considered as a risk biomarker associated with poor outcome in various low-grade inflammation and infectious diseases. The study is aimed at inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zuxiong, Wang, Ning, Huang, Shuiwen, Chen, Yi, Yang, Shida, Gan, Qiaorong, Ye, Hanhui, Liu, Baorong, Pan, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525912/
https://www.ncbi.nlm.nih.gov/pubmed/31191644
http://dx.doi.org/10.1155/2019/3467690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525912/
https://www.ncbi.nlm.nih.gov/pubmed/31191644
http://dx.doi.org/10.1155/2019/3467690

Ejemplares similares